Medical Science News

RSS

Mind Technologies to sell Emotiv EEG headset

Mind Technologies, Inc., announced today that the Company will begin selling the Emotiv EEG headset in addition to the thought-controlled software applications the Company develops.

20 Dec 2010

Spartan RX CYP2C19 DNA testing system receives European CE Mark certification

Spartan Bioscience Inc., a privately held molecular diagnostics company that develops, manufactures, and markets DNA testing systems for on-demand applications, today announced its Spartan RX CYP2C19 received a CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices. The CE Mark certification allows commercial distribution in Europe as well as in all countries recognizing the CE Mark in the Middle East, Africa, Latin America, and Asia-Pacific regions.

20 Dec 2010

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Arrowhead Research Corporation today announced that it has executed an exclusive world-wide license on technology developed by Drs. Wadih Arap and Renata Pasqualini at MD Anderson Cancer Center for use in weight loss and obesity-related metabolic conditions, and that it has launched a new company, Ablaris Therapeutics Inc., to commercialize this platform.

20 Dec 2010

Hyperpriming in early stages of Alzheimer's disease explained

The capacity to remember that a zebra has stripes, or that a giraffe is a four-legged mammal, is known as semantic memory. It allows us to assign meaning to words and to recall general knowledge and concepts that we have learned. The deterioration of these capacities is a defining feature of semantic dementia and can also occur in Alzheimer's disease.

20 Dec 2010

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has demonstrated the ability to capture immunosuppressive exosomes derived from individuals with lymphoma and colorectal cancer.

20 Dec 2010

FVCG invests $175,000 in Celvive for stem cell research in spinal cord injury

Spinal cord injury (SCI) is a devastating neurological condition with limited therapeutic options. In the United States alone, there are more than 250,000 people living with SCI; approximately three million worldwide are affected.

20 Dec 2010

State Roundup: UMass bone marrow registry practices probed; Insurance woes hit many Calif. middle income families

Bone marrow registries are usually noble efforts to find donors with the right genetic match to save the life of a terminally ill person, but one such program in New England is under investigation by attorneys general in two states (Greenberg, 12/17).

20 Dec 2010

Medical breakthrough: Scientists grow functioning human intestinal tissue from stem cells

Emerging Healthcare Solutions was encouraged by the latest breakthrough in stem cell research this week when scientists at Cincinnati Children's Hospital Medical Center announced that they've grown functioning human intestinal tissue from stem cells for the first time.

20 Dec 2010

Scientists suggest targeting ion channels could offer effective pain relief

University at Buffalo neuroscience researchers conducting basic research on ion channels have demonstrated a process that could have a profound therapeutic impact on pain.

20 Dec 2010

First comprehensive textbook on psychology for medical students

Psychology for medicine, published today by SAGE, is the first comprehensive textbook on psychology for medical students that is relevant to all of their undergraduate studies. Following the General Medical Council's call for greater coverage of psychology throughout medical degree courses, this groundbreaking textbook does just that - presenting all the psychology an undergraduate medical student needs to know.

17 Dec 2010

Goji berries' components are available in fruits and vegetables

A University of Granada professor specialist in Nutrition explained that the species Lycium Barbarum -currently imported from China- comes from the Mediterranean regions and grows in other mild regions of the world. Also, he stated that "Goji berries will not have any positive effect on people that do not follow a balanced diet".

17 Dec 2010

Amira identifies novel pre-clinical candidate for autotaxin lysophosphatidic acid related program

Amira Pharmaceuticals, Inc. announced today that it has successfully identified a novel pre-clinical candidate for its newest lysophosphatidic acid (LPA)-related program, autotaxin. Autotaxin is an enzyme upstream from LPA receptors and has been implicated in a number of diseases including rheumatoid arthritis, glioblastoma, lung, breast, ovarian and thyroid cancers.

17 Dec 2010

Possible stem cell cure for AIDS

An explosion of stem cell breakthroughs, including a possible cure for AIDS, is reshaping the possibilities for curing deadly and debilitating diseases around the globe, says Emerging Healthcare Solutions President and CEO Cindy Morrissey.

17 Dec 2010

Sustainable Phosphorus Summit, Feb. 3-5, 2011

What element is commonly found in every living creature on Earth yet may become scarce in our lifetimes? If you answer phosphorus, you-d be one of only a few individuals in tune with scientists and governments aware of limitations in this mined resource.

17 Dec 2010

23andMe project aims at validating highly scalable pharmacogenomics research

23andMe has launched a project funded by the National Institutes of Health which is aimed at validating 23andMe's highly-scalable platform for pharmacogenomics research. The company received $190,000 in stimulus funding from the American Recovery and Reinvestment Act of 2009 for "Web-based Phenotyping for Genome-Wide Association Studies of Drug Response" from NIH's National Human Genome Research Institute.

17 Dec 2010

Astonishing diversity of microbes inhabit the human body

A mounting tide of scientific evidence suggests that the old adage from Aesop's fables - "You are known by the company you keep" - also applies to the trillions of microscopic bacteria and viruses that live on the human body. Humanity's invisible but constant companions - more bacteria hang out on the palms of your hands than there are people on Earth - is the topic of an article in the current edition of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

17 Dec 2010

Celator granted U.S. Patent covering CombiPlex technology platform

Celator Pharmaceuticals today announced the United States Patent and Trademark Office issued U.S Patent No. 7,850,990. This patent adds to the intellectual property surrounding Celator's innovative technology platforms and products.

17 Dec 2010

Researchers contribute important expertise to new landmark study of medulloblastoma

Pediatric cancer researchers at The Children's Hospital of Philadelphia contributed important expertise to a new landmark study of medulloblastoma, a type of brain tumor typically found in children. The large multicenter study defines the genetic landscape of this cancer, and holds intriguing clues to gene changes on signaling pathways that may become fruitful targets for future therapies.

17 Dec 2010

Researchers discover new way to prevent spread of cancer

Scientists now know that some cancer cells spread, or metastasize, throughout the body the old-fashioned way -- by using their feet. But researchers at Duke Cancer Institute have discovered a way to short-circuit their travels by preventing the development of these feet, called invadopodia. This discovery is even more important because preventing the development of these "feet" also eliminates the action of proteins present in the feet that burn through intact tissue and let cancer cells enter new cells.

17 Dec 2010

BioMimetic granted Canadian notice of patent allowance covering rhPDGF-BB platform technology formulations

BioMimetic Therapeutics, Inc. announced today the Canadian Intellectual Property Office (CIPO) has allowed patent application No. 2,583,823 titled "Platelet Derived Growth Factor (PDGF) Compositions and Methods of Use Thereof". The new patent will remain in force until October 2025, during which time it will prohibit the marketing of similar or generic versions of the Company's Augment™ orthopedic product line and certain other rhPDGF-BB product formulations.

17 Dec 2010